Prudential Financial
ADCT icon

Prudential Financial’s ADC Therapeutics ADCT Stock Holding History

Prudential Financial’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.6K Buy
+26,295
New +$104K ﹤0.01% 2235
2025
Q1 		– Sell
-17,430
Closed -$34.7K – 2286
2024
Q4 		$34.7K Buy
+17,430
New +$45.6K ﹤0.01% 2240

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prudential Financial's ADCT Position: Q1 2026 in Review

Prudential Financial opened a new position in ADC Therapeutics (ADCT) in Q1 2026: 26,295 shares worth $98.6K. The stake represents ﹤0.01% of the portfolio and ranks #2235 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ADCT as recently as Q4 2024.

Prudential Financial first reported a position in ADCT in Q4 2024 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Prudential Financial held 26,295 shares of ADC Therapeutics worth $98.6K as of Q1 2026.
  • ADC Therapeutics was a new Prudential Financial position in Q1 2026.
  • ADC Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2235 holding.
  • Prudential Financial first reported a position in ADC Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.